Nanomedicina
Biodegradable silica nanoparticles for efficient linear DNA gene delivery
A Ramos-Valle; H Kirst, ML Fanarraga
Drug Delivery 2024, 31:2385376 doi.org/10.1080/10717544.2024.2385376
L García-Hevia, R Soltani; J González, O Chaloin; C Ménard-Moyon; A Bianco, ML Fanarraga
Bioactive Materials 2024, 34:237-247 (pdf)
A Villasante, ...., ML Fanarraga, J Samitier
Cancers 2024, 16(5),1060 (pdf)
A Fernández-Borbolla, L García-Hevia, ML Fanarraga
Int. J. Mol. Sci. 2024, 25(4), 2071 (pdf)
Solid Lipid Nanoparticles Enhancing the Leishmanicidal Activity of Delamanid
J Santamaría-Aguirre, D Jacho, MA Méndez, A Poveda, J Carrión, ML Fanarraga
Pharmaceutics 2024, 16(1):41 (pdf)
Enhanced inhibition of amyloid formation by heat shock protein 90 immobilized on nanoparticles
A Rodriguez-Ramos, JA. González, ML Fanarraga
ACS Chemical Neuroscience 2023, 14(15):2811–2817 (pdf)
AB Toxins as High-Affinity Ligands for Cell Targeting in Cancer Therapy
A Márquez-López, ML Fanarraga
Int. J. Mol. Sci. 2023, 24(13):11227 (pdf)
A Ramos-Valle; L Marín-Cava, L García Hevia, MA Correa-Duarte, ML Fanarraga
Material Today Advances 2023, 18:100357 (pdf)
Nanoparticle biocoating to create ATP-powered swimmers capable of repairing proteins on the fly
A Rodriguez-Ramos, MA. Ramos-Docampo, V Salgueiriño, ML Fanarraga
Material Today Advances 2023, 17:100353 (pdf)
Magnetically Propelled Chained Nanocomposites for On-Demand Biologically Relevant Media Exploration
MA. Ramos-Docampo, P Hurtado, AB. Dávila-Ibáñez, R Piñeiro, ML Fanarraga, V Salgueiriño
Journal of Colloid and Interface Science 2023, 629: 287-296 (pdf).
E Navarro-Palomares, L García-Hevia, J Galán-Vidal, A Gandarillas, F García-Reija, A Sánchez-Iglesias, LM Liz-Marzán, R Valiente, ML Fanarraga
International Journal of Nanomedicine, 2022, 17:5747-5760 (pdf).
Gb3/CD77 Is a Predictive Marker and Promising Therapeutic Target for Head and Neck Cancer
L García-Hevia, D Muñoz-Guerra, Í Casafont, C Morales-Angulo, V J. Ovejero, D Lobo, ML Fanarraga
Biomedicines, 2022, 10(4):732 (pdf).
A Mateu-Roldán B Zhong, D Muñoz-Guerra, J González, MR Ibarra, M King, ML Fanarraga* C Marquina*
Chemical Engineering Journal (2022) 435, 134466 (pdf).
E Navarro-Palomares, L García-Hevia, E Padín-González, M Bañobre-López, JC Villegas, R Valiente and ML Fanarraga.
Cancers, 2021, 13(19): 492 (pdf).
**Magnetic lipid nanovehicles synergize the controlled thermal release of chemotherapeutics with magnetic ablation while enabling non-invasive monitoring by MRI for melanoma theranostics**
L García-Hevia, Í Casafont, J Oliveira, N Terán, ML Fanarraga, J Gallo, M Bañobre-López
Bioactive Materials 2022, 8:153-164 (pdf).
L García-Hevia, M Saramiforoshani, J Monge , N Iturrioz, E Padin, F González, L González-Legarreta, J González, ML Fanarraga
Journal of Nanobiotechnology 2021, 19:129 (pdf)
Solid-lipid particles for lung metastasis treatment
L Valdivia, L García-Hevia, M Bañobre-López, J Gallo, R Valiente, ML Fanarraga
Pharmaceutics 2021, 13(1): 93 (pdf)
Free-labeled nanoclay intracellular uptake tracking by confocal Raman imaging
N Iturrioz-Rodríguez, R Martín-Rodríguez, C Renero, F Aguado, L González-Legarreta, J González, ML Fanarraga, AC Perdigón
Applied Surface Science, 2021, 537:147870 (pdf)
Design of polymeric and biocompatible delivery systems by dissolving mesoporous silica templates
Rodríguez-Ramos A, Marín-Caba L, Iturrioz-Rodríguez N, Padín-González E, García-Hevia L, Mêna-Oliveira T, Corea-Duarte MA and Fanarraga ML
Int. J. Mol. Sci. 2020, 21(24): 9573 (pdf)
**Microtubule cytoskeleton-disrupting activity of MWCNTs: Applications in cancer treatment
L García-Hevia & ML. Fanarraga
Journal of Nanobiotechnology, 2020, 18(1):181 (pdf)
L González-Legarreta, C Renero-Lecuna, R Valiente, ML Fanarraga
Analytical Methods 2020, 12(46): 5642 (pdf)
A custom-made functionalization method to control the biological identity of nanomaterials
E Padín-González, E Navarro-Palomares, L. Valdivia, N Iturrioz-Rodríguez, MA Correa-Duarte, R Valiente and ML Fanarraga
Nanomedicine 2020, 02268; DOI: 10.1016/j.nano.2020.102268 (pdf)
N Iturrioz-Rodríguez, MA Correa-Duarte, R Valiente, ML Fanarraga
Pharmaceutics 2020: 12(6), 487 (pdf)
E Navarro-Palomares, P González-Saiz, C Renero-Lecuna, R Martín Rodríguez, F Aguado, D González-Alonso, L Fernandez Barquin, J Gonzalez, M Bañobre-López, M L Fanarraga & R Valiente
Nanoscale, 2020:12, 6164-6175 (pdf)
Controlled drug delivery systems for cancer-based on mesoporous silica particles
N Iturrioz-Rodríguez, M A. Correa-Duarte , M L. Fanarraga
Int J Nanomedicine (2019) 14: 3389-3401
Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil
E González-Lavado, L Valdivia, A García-Castaño, F González, C Pesquera, R Valiente, M. L. Fanarraga
Oncotarget, 2019, 10:2022-2029 (pdf)
Effect of Size, Shape, and Composition on the Interaction of Different Nanomaterials with HeLa Cells
C Renero-Lecuna, N Iturrioz-Rodríguez, E González-Lavado, E Padín-González, E Navarro-Palomares, L Valdivia-Fernández, L García-Hevia, M L. Fanarraga, L González-Legarreta
J Nanomaterials, 2019, Article ID 7518482 (pdf)
Biodegradable multi-walled carbon nanotubes trigger antitumoral effects
E. González-Lavado, N. Iturrioz-Rodriguez, E. Padín-González, J. González, L. García-Hevia, J. Heurts, C. Pesquera, F. González, JC. Villegas, R. Valiente, ML. Fanarraga
Nanoscale. 2018 Jun 14;10(23):11013-11020.
Drug Nanoparticle Stability Assessment Using Isothermal and Non-Isothermal Approaches
J. Santamaría-Aguirre, R. Alcocer-Vallejo, M. L. Fanarraga
J Nanomaterials, 2018, Article ID 3047178. (pdf)
**A synthetic getaway biomimetic strategy for cytoplasm particle invasion**
N. Iturrioz-Rodríguez, E. González-Domínguez, E. González-Lavado, L. Marín-Caba, B. Vaz, M. Pérez-Lorenzo, M. A. Correa-Duarte and M. L. Fanarraga
Angewandte Chemie Int. Ed. (2017) 56(44):13736-13740
(paper, supp info, video1, video2)
E. González-Domínguez, N. Iturrioz, E. Padín-González, J. C. Villegas, L. García-Hevia, M. Pérez-Lorenzo, W. J. Parak, M. A. Correa-Duarte, M. L. Fanarraga
Int. J. Nanomedicine (2017)12: 6317–6328
Bio-degradable carbon nanotubes display intrinsic anti-tumoral effect
Mónica L Fanarraga, Eloisa González-Lavado, Esperanza Padín-González and Nerea Iturrioz
J Biotechnol Biomater (2017) 7: 2
Multi-walled carbon nanotubes (MWCNTs) as cytotoxic drug delivery systems in the treatment of cancer
Eloisa Gonzalez-Lavado, Esperanza Padin-Gonzalez, Nerea Iturrioz, Tomas Torroba and Monica L Fanarraga
J Biotechnol Biomater (2017) 7: 2
**Magnetic hyperthermia enhances cell toxicity with respect to exogenous heating**
B Sanz, M P Calatayud, T E Torres, M L. Fanarraga, M. R Ibarra, G F. Goya
L. García-Hevia, R. Valiente, R. Martín Rodríguez, C. Renero Lecua, J.A. Gonzalez, L. Rodríguez Fenández, F. Aguado, J. C. Villegas, M. L. Fanarraga
Nanoscale (2016) 8(21):10963-73
Multiwalled carbon nanotubes inhibit tumor progression in a mouse model
García-Hevia L, Villegas JC, Fernández F, Casafont I, González J, Valiente R and Fanarraga ML
Advanced Healthcare Materials (2016) (9):1080-7.
A fast, reliable and cost-effective method to generate tumor organs for therapy screening in vivo
García-Hevia L, Fernández F, Casafont I, Villegas JC and Fanarraga ML
Biomedical Physics & Engineering Express (2016) 035009.
**Inhibition of Cancer Cell Migration by Multiwalled Carbon Nanotubes**
L. García-Hevia, R. Valiente, J.L. Fernández-Luna, E. Flahaut, L. Rodríguez-Fernández, J.C. Villegas, J. González, M.L. Fanarraga
Adv Healthc Mater. (2015) 4(11):1640-4
Anti-Cancer Cytotoxic Effects of Multiwalled Carbon Nanotubes
García-Hevia L, Valiente R, González J, Fernández-Luna JL, Villegas JC, Fanarraga, ML
Current Pharmaceutical Design (2015) 21:1920-1929
Nanotube interactions with microtubules: implications for cancer medicine
García-Hevia L, Fernández F, Grávalos C, García A, Villegas JC, Fanarraga ML
Nanomedicine 2014 Jul;9(10):1581-8
Villegas JC, Alvarez-Montes L, Rodríguez-Fernández L, González J, Valiente R, Fanarraga ML.
Adv Healthc Mater. 2014 Mar;3(3):424-32
Rodriguez-Fernandez L, Valiente R, Gonzalez J, Villegas JC, Fanarraga ML.
ACS Nano. 2012 Aug 28;6(8):6614-25.